Dr. Abidi Pharmaceutical Laboratory engages in the research and development, manufacture, and sale of pharmaceuticals. It provides analgesics, anthelmintics, antidiabetics, antihistaminics, antiinfectives, antirheumatics, bone resorption inhibitors, CNS agents, cold products, CVS and GI agents, and nutritional supplements. The company offers its medicines in various dosage forms, such as oral liquids/syrups, gels, semi-solids, capsules, tablets, and ointments. It serves customers through a distributor agency in Iran and internationally.
Company Profile | |
CEO: | Mr. Amir Razavian |
Year of foundation: | 1946 |
Number of employees: | 574 |
Market Capitalization: | 17,325.504 billion IRR (April 2018) |
Symbol at TSE: | ABDI |
Floated shares: | 9% |
Total Revenue : | 4,011,093 million IRR (2017)
106 million USD1 |
Net Profit: | 747,985 million IRR |
Main Shareholders | Percentage |
Cobel Darou | 67.06% |
Lian Investment Company | 19.91% |
Arian Alvand Pars Company | 4.0% |
Private Investor | 1.9% |
Others | 7.13% |
Products | |
Osteoporosis: | Alenate 70 |
Antibiotics: | Tavanex 500 |
Tavanex 750 | |
Virabex 500 | |
Virabex 1000 | |
Metronidazole 250 | |
Sofira 400 | |
Cold Analgesics: | · Children Corizan: Cold & Flu
· Children Corizan: Pain & Fever · Children Corizan: Grippe |
· Coldax: Sinus & Allergy
· Coldax: Day & Night · Coldax: Flu |
|
Advalgin Cold | |
· Corizan: Day & Night
· Corizan: Adult Cold |
|
Analgesics: | Advalgin Flash 400 |
Codimal Extra | |
Naproxen 500 | |
Gastrointestinal: | · Pantoprazole 20
· Pantoprazole 40 |
Clidinium C | |
· Lanzo 15
· Lanzo 30 |
|
Motidon | |
· Ezonium 20
· Ezonium 40 |
|
Ondansetron | |
Merazole 20 | |
Psychology: | · Alprazolam 0.5
· Alprazolam 1 |
· Sertraline 50
· Sertraline 100 |
|
· Chlordiazepoxide 5
· Chlordiazepoxide 10 |
|
· Lorazepam 1
· Lorazepam 2 |
|
· Loxeta 20
· Loxeta 30 · Loxeta 60 |
|
· Wellban 75
· Wellban ER 150 |
|
· Venabid 37.5
· Venabid 75 · Venabid ER 37.5 · Venabid ER 75 |
|
· Citalex 20
· Citalex 40 |
|
· Nortriptyline 10
· Nortiptyline 25 |
|
· Flouxetine 10
· Flouxetine 20 |
|
Anti-Diabetes: | Diabezid 80 |
Zipmet 50/500 | |
· Ziptin 50
· Ziptin 100 |
|
· Diabezid 30 MR
· Diabezid 60 MR |
|
· Gelomet 500
· Gelomet 1000 |
|
Respiratory: | · Airokast 5
· Airokast 10 |
Ketotifen | |
Cardiovascular: | · Atovast 10
· Atovast 20 · Atovast 40 |
· Enalapril 5
· Enalapril 20 |
|
· Propranolol 10
· Propranolol 20 |
|
Gem Fibrozil 450 | |
· Ropixon 5
· Ropixon 10 · Ropixon 20 · Ropixon 40 |
|
· Zestprel 5
· Zestprel 10 · Zestprel 20 |
|
· Cardilex 6.25
· Cardilex 12.5 · Cardilex 25 |
|
· Lostar 25
· Lostar 50 |
|
· Valzomix 5/160
· Valzomix 5/80 |
|
Gem Fibrozil 300 |
History of the Company
Dr. Gholamali Abidi, 1920-2004, was born in Tehran. He was graduated from the Medical Faculty of the University of Tehran in 1938 and he was graduated in 1942. Then, he went to Paris for passing the internship course.
The pitiable condition of the patients during the world war second made him produce national medicine in Iran. This decision led to the establishment of the first pharmaceutical laboratory in the country in 1946 at Amin District in Tehran. In 1958, he obtained the first pharmaceutical license from the Ministry of Health for “Vermicid Tablet” Dr. Abidi Pharmaceutical Laboratory was established in 1973 in a 10000-suqre-meter land at Karaj Road, which has been active from that time till now. In 1999, Dr. Abidi Pharmaceuticals received ISO 9001 Certificate in quality management from BVQI Co. of England. In 2001, the quality control laboratory of Dr. Abidi Pharmaceuticals received the accredited certificate from the Ministry of Health. In 2002, a branch of Dr. Abidi Pharmaceutical Laboratory was established in Samarkand, Uzbekistan at the presence of the current president. Dr. Gholamali Abidi was a pious and good man and he loved science and production. He was very energetic and thought beyond his time. Finally, the old father of Iranian Pharmaceutical Industry died on 2004. Cobel Darou, as the top pharmaceutical importer in Iran, bought more than 90 percent of the shares of Dr. Abidi Pharmaceuticals.
1: Official exchange rate used on the date of publication; 1 USD equivalent to 37,820 IRR.